Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy
2022-01-01 Vitello, A; Grova, M; Pugliese, D; Rizzello, F; Lanzarotto, F; Lavagna, A; Caccaro, R; Cappello, M; Viola, A; Ribaldone, Dg; Principi, M; Stasi, E; Scribano, Ml; Maida, M; Soriano, A; Bezzio, C; Bodini, G; Mocciaro, F; Privitera, Ac; Simondi, D; Giuffrida, E; D'Incà, R; Ricci, C; Gionchetti, P; Armuzzi, A; Orlando, A; Daperno, M; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD)
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre
2020-01-01 Napolitano, D; Martella, P; Schiavoni, E; Turchini, L; Amatucci, V; Armuzzi, A; Cocchieri, A; Zega, M; Scaldaferri, F; Gasbarrini, A
Occurrence of inflammatory bowel disease in central Italy: a study based on health information systems
2014-01-01 Di Domenicantonio, R; Cappai, G; Arcà, M; Agabiti, N; Kohn, A; Vernia, P; Biancone, L; Armuzzi, Alessandro; Papi, C; Davoli, M.
Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease
2020-01-01 Macaluso, Fs; Leone, S; Previtali, E; Ventimiglia, M; Armuzzi, A; Orlando, A; AMICI (Italian Inflammatory Bowel Disease Patients' Association) and IG-IBD (Italian Group for the Study of Inflammatory Bowel, Disease)
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade
2020-01-01 Pugliese, D; Armuzzi, A; Castri, F; Benvenuto, R; Mangoni, A; Guidi, L; Gasbarrini, A; Rapaccini, Gl; Wolf, Fi; Trapani, V
Novel Topics in Inflammatory Bowel Disease
2016-01-01 Sakuraba, A; Armuzzi, A; Keyashian, K; Naganuma, M
Extradigestive manifestations of Helicobacter pylori gastric infection
1999-01-01 Gasbarrini, A; Franceschi, F; Armuzzi, A; Ojetti, V; Candelli, M; Torre, Es; De Lorenzo, A; Anti, M; Pretolani, S; Gasbarrini, G
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease
2021-01-01 Privitera, G; Onali, S; Pugliese, D; Renna, S; Savarino, E; Viola, A; Ribaldone, Dg; Buda, A; Bezzio, C; Fiorino, G; Fantini, Mc; Scaldaferri, F; Guidi, L; Danese, S; Gasbarrini, A; Orlando, A; Armuzzi, A
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study
2021-01-01 Vetrugno, G; Laurenti, P; Franceschi, F; Foti, F; D'Ambrosio, F; Cicconi, M; LA Milia, Di; Di Pumpo, M; Carini, E; Pascucci, D; Boccia, S; Pastorino, R; Damiani, G; De-Giorgio, F; Oliva, A; Nicolotti, N; Cambieri, A; Ghisellini, R; Murri, R; Sabatelli, G; Musolino, M; Gasbarrini, A; Gemelli-Against-Covid, Group; Armuzzi, A
Reply to Dr. Kotze's and Dr. Yamamoto's letter
2013-01-01 Armuzzi, Alessandro; Felice, C.
Patient Engagement in Health Management as a Mediator Between Perceived Risk and COVID-19 Related Distress in Patients With IBD: A Structural Equation Model
2021-01-01 Castellini, G; Palamenghi, L; Savarese, M; Barello, S; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G
C-13-methionine breath tests for mitochondrial liver function assessment
2008-01-01 Candelli, M; Miele, L; Armuzzi, A; Nista, Ec; Pignataro, G; Fini, L; Cazzato, Ia; Zocco, Ma; Bartolozzi, F; Gasbarrini, G; Grieco, A; Gasbarrini, A
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study
2018-01-01 Guidi, L; Pugliese, D; Panici Tonucci, T; Berrino, A; Tolusso, B; Basile, M; Cantoro, L; Balestrieri, P; Civitelli, F; Bertani, L; Marzo, M; Felice, C; Gremese, E; Costa, F; Viola, F; Cicala, M; Kohn, A; Gasbarrini, A; Rapaccini, Gl; Ruggeri, M; Armuzzi, A
Reply to Dr. Joob et al.'s letter
2013-01-01 Andrisani, G; Armuzzi, Alessandro
IBD: Infliximab dose optimization in IBD-proactive or reactive?
2014-01-01 Armuzzi, Alessandro; Felice, C.
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
2014-01-01 Armuzzi, Alessandro; Gasbarrini, Antonio; Guidi, Luisa
Psychological reaction to Covid-19 of Italian patients with IBD
2021-01-01 Savarese, M; Castellini, G; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G
Mucosal healing in ulcerative colitis: surveillance or colectomy?
2013-01-01 Andrisani, G; Papa, A; Guidi, L; Armuzzi, A
Review article: breath testing for human liver function assessment
2002-01-01 Armuzzi, A; Candelli, M; Zocco, Ma; Andreoli, A; De Lorenzo, A; Nista, Ec; Miele, L; Cremonini, F; Cazzato, Ia; Grieco, A; Gasbarrini, G; Gasbarrini, A
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
2013-01-01 Armuzzi, Alessandro; Pugliese, Daniela; Nardone, Om; Guidi, Luisa
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy | 1-gen-2022 | Vitello, A; Grova, M; Pugliese, D; Rizzello, F; Lanzarotto, F; Lavagna, A; Caccaro, R; Cappello, M; Viola, A; Ribaldone, Dg; Principi, M; Stasi, E; Scribano, Ml; Maida, M; Soriano, A; Bezzio, C; Bodini, G; Mocciaro, F; Privitera, Ac; Simondi, D; Giuffrida, E; D'Incà, R; Ricci, C; Gionchetti, P; Armuzzi, A; Orlando, A; Daperno, M; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD) | |
| The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre | 1-gen-2020 | Napolitano, D; Martella, P; Schiavoni, E; Turchini, L; Amatucci, V; Armuzzi, A; Cocchieri, A; Zega, M; Scaldaferri, F; Gasbarrini, A | |
| Occurrence of inflammatory bowel disease in central Italy: a study based on health information systems | 1-gen-2014 | Di Domenicantonio, R; Cappai, G; Arcà, M; Agabiti, N; Kohn, A; Vernia, P; Biancone, L; Armuzzi, Alessandro; Papi, C; Davoli, M. | |
| Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease | 1-gen-2020 | Macaluso, Fs; Leone, S; Previtali, E; Ventimiglia, M; Armuzzi, A; Orlando, A; AMICI (Italian Inflammatory Bowel Disease Patients' Association) and IG-IBD (Italian Group for the Study of Inflammatory Bowel, Disease) | |
| TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade | 1-gen-2020 | Pugliese, D; Armuzzi, A; Castri, F; Benvenuto, R; Mangoni, A; Guidi, L; Gasbarrini, A; Rapaccini, Gl; Wolf, Fi; Trapani, V | |
| Novel Topics in Inflammatory Bowel Disease | 1-gen-2016 | Sakuraba, A; Armuzzi, A; Keyashian, K; Naganuma, M | |
| Extradigestive manifestations of Helicobacter pylori gastric infection | 1-gen-1999 | Gasbarrini, A; Franceschi, F; Armuzzi, A; Ojetti, V; Candelli, M; Torre, Es; De Lorenzo, A; Anti, M; Pretolani, S; Gasbarrini, G | |
| Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease | 1-gen-2021 | Privitera, G; Onali, S; Pugliese, D; Renna, S; Savarino, E; Viola, A; Ribaldone, Dg; Buda, A; Bezzio, C; Fiorino, G; Fantini, Mc; Scaldaferri, F; Guidi, L; Danese, S; Gasbarrini, A; Orlando, A; Armuzzi, A | |
| Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study | 1-gen-2021 | Vetrugno, G; Laurenti, P; Franceschi, F; Foti, F; D'Ambrosio, F; Cicconi, M; LA Milia, Di; Di Pumpo, M; Carini, E; Pascucci, D; Boccia, S; Pastorino, R; Damiani, G; De-Giorgio, F; Oliva, A; Nicolotti, N; Cambieri, A; Ghisellini, R; Murri, R; Sabatelli, G; Musolino, M; Gasbarrini, A; Gemelli-Against-Covid, Group; Armuzzi, A | |
| Reply to Dr. Kotze's and Dr. Yamamoto's letter | 1-gen-2013 | Armuzzi, Alessandro; Felice, C. | |
| Patient Engagement in Health Management as a Mediator Between Perceived Risk and COVID-19 Related Distress in Patients With IBD: A Structural Equation Model | 1-gen-2021 | Castellini, G; Palamenghi, L; Savarese, M; Barello, S; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G | |
| C-13-methionine breath tests for mitochondrial liver function assessment | 1-gen-2008 | Candelli, M; Miele, L; Armuzzi, A; Nista, Ec; Pignataro, G; Fini, L; Cazzato, Ia; Zocco, Ma; Bartolozzi, F; Gasbarrini, G; Grieco, A; Gasbarrini, A | |
| Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study | 1-gen-2018 | Guidi, L; Pugliese, D; Panici Tonucci, T; Berrino, A; Tolusso, B; Basile, M; Cantoro, L; Balestrieri, P; Civitelli, F; Bertani, L; Marzo, M; Felice, C; Gremese, E; Costa, F; Viola, F; Cicala, M; Kohn, A; Gasbarrini, A; Rapaccini, Gl; Ruggeri, M; Armuzzi, A | |
| Reply to Dr. Joob et al.'s letter | 1-gen-2013 | Andrisani, G; Armuzzi, Alessandro | |
| IBD: Infliximab dose optimization in IBD-proactive or reactive? | 1-gen-2014 | Armuzzi, Alessandro; Felice, C. | |
| Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy | 1-gen-2014 | Armuzzi, Alessandro; Gasbarrini, Antonio; Guidi, Luisa | |
| Psychological reaction to Covid-19 of Italian patients with IBD | 1-gen-2021 | Savarese, M; Castellini, G; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G | |
| Mucosal healing in ulcerative colitis: surveillance or colectomy? | 1-gen-2013 | Andrisani, G; Papa, A; Guidi, L; Armuzzi, A | |
| Review article: breath testing for human liver function assessment | 1-gen-2002 | Armuzzi, A; Candelli, M; Zocco, Ma; Andreoli, A; De Lorenzo, A; Nista, Ec; Miele, L; Cremonini, F; Cazzato, Ia; Grieco, A; Gasbarrini, G; Gasbarrini, A | |
| Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab | 1-gen-2013 | Armuzzi, Alessandro; Pugliese, Daniela; Nardone, Om; Guidi, Luisa |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891